{
  "N/R/U": null,
  "Applicant": "Samsung Bioepis Co., Ltd.",
  "BLA Number": "761202",
  "Proprietary Name": "Byooviz",
  "Proper Name": "ranibizumab-nuna",
  "BLA Type": "351(k) Interchangeable",
  "Strength": "10MG/ML",
  "Dosage Form": "Injection ",
  "Route of Administration": "Intravitreal",
  "Product Presentation": "Single-Dose Vial",
  "Marketing Status": "Rx",
  "Licensure": "Licensed",
  "Approval Date": "17-Sep-21",
  "Ref. Product Proper Name": "ranibizumab",
  "Ref. Product Proprietary Name": "Lucentis",
  "Supplement Number": null,
  "Submission Type": "Original",
  "License Number": "2046",
  "Product Number": "1",
  "Center": "CDER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": null
}